A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Express Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could result in users administering substances of uncertain source.
Some professionals stated the demand for the experimental drug could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Elimination
Based on the social media company, the service has taken down problematic content and banned related keywords and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.
Digital Trading Activities
Research also found groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, positive reviews and step-by-step instructions for mixing or administering at home.
After minutes of joining one community, a seller posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.
Product Information and Pricing
Inside these groups, posts show black plastic packages with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for the messaging service said it regularly moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has already encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to possibly serious medical dangers”.
